QoL data support use of ultra-hypofractionated radiotherapy in prostate cancer

Among patients with 6 years’ follow-up, no differences were observed between ultra-hypofractionation and conventional fractionation in the rates of clinically relevant deterioration in overall urinary bother, overall bowel bother, overall sexual bother, or global health/QoL.

Read the full article here

Related Articles